Select a State

Global health R&D delivers for Maryland

US government investment in global health R&D has delivered

$2.5 billion
to Maryland research institutions
30,700+ new jobs
for Maryland
4468

Neglected diseases in Maryland

Chikungunya cases
86
Dengue cases
60
HIV diagnoses
13396
Malaria cases
804
Tuberculosis cases
1941
West Nile cases
177
Zika cases
142

Maryland

--

Maryland's top USG-funded global health R&D institutions

National Institutes of Health (self-funding and other agency transfers)
$ 1.6 billion
Johns Hopkins University
$ 222.5 million
The Henry M. Jackson Foundation for the Advancement of Military Medicine
$ 221.9 million
U.S. Army Fort Detrick
$ 151.8 million
University of Maryland, Baltimore
$ 108.6 million
International Partnership for Microbicides
$ 44.7 million
Leidos Biomedical Research
$ 39.6 million
Westat Inc.
$ 28.5 million
Walter Reed Army Institute of Research (including Military HIV Research Program)
$ 17.8 million
Technical Resources International, Inc.
$ 17.7 million

Maryland industry in global health R&D

Accelovance
Location(s):
Rockville
AstraZeneca
Location(s):
Frederick, Gaithersburg
Biological Mimetics
Location(s):
Frederick
Celgene
Location(s):
Odenton
Charles River Laboratories
Location(s):
Frederick, Germantown
Eisai
Location(s):
Baltimore
Emergent Biosolutions
Location(s):
Baltimore, Gaithersburg, Rockville
EMMES Corporation
Location(s):
Frederick, Rockville
Fyodor Bio
Location(s):
Baltimore
Genvec
Location(s):
Gaithersburg
item[company]
Location(s):
Rockville
item[company]
Location(s):
Rockville
item[company]
Location(s):
Gaithersburg
item[company]
Location(s):
Bethesda, Fort Detrick, Frederick
item[company]
Location(s):
Bethesda
item[company]
Location(s):
Rockville
item[company]
Location(s):
Bethesda, Silver Spring
item[company]
Location(s):
Gaithersburg
item[company]
Location(s):
Bethesda
item[company]
Location(s):
Baltimore
item[company]
Location(s):
Rockville
item[company]
Location(s):
Frederick, Germantown
item[company]
Location(s):
Rockville
item[company]
Location(s):
Rockville
item[company]
Location(s):
Baltimore
item[company]
Location(s):
Gaithersburg
item[company]
Location(s):
Bethesda
item[company]
Location(s):
Gaithersburg
item[company]
Location(s):
Rockville

Maryland's top areas of global health R&D by USG funding

60.6%
HIV/AIDS
14.9%
Tuberculosis
2.3%
Diarrheal diseases
9.3%
Neglected tropical diseases
Dengue
Helminths
Kinetoplastids
Leprosy
Trachoma
5.9%
Other
Bacteria pneumonia & meningitis
Cryptococcal meningitis
Ebola/viral hemorrhagic fevers
Salmonella infections
Rheumatic fever

Global health R&D at work in Maryland

The University of Maryland has developed a vaccine, Vaxchora™, to protect US adults traveling to cholera-affected areas. Vaxchora is the only cholera vaccine available in the United States, and the only single-dose vaccine for cholera licensed anywhere. Acquired through contaminated food or water, cholera can kill in less than 24 hours if left untreated. Widespread in 69 countries, this highly contagious disease impacts millions of people worldwide each year.

Footnotes